ArticleCardio-oncology (London, England)2024

Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.

Jian Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.